Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lisinopril
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved
Recipient : Alvogen
Deal Size : $350.0 million
Deal Type : Acquisition
Aztiq Buys 17% Stake in Alvogen US
Details : Zestril (lisinopril) belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. Zestril is used to treat high blood pressure (hypertension) in adults and children who are at least 6 years old.
Brand Name : Zestril
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 30, 2021
Lead Product(s) : Lisinopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Recipient : Alvogen
Deal Size : $350.0 million
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?
Reset All
